
Balsalazide disodium dihydrate NEW
Price | $39 | $59 | $105 |
Package | 5mg | 10mg | 25mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2025-07-16 |
Product Details
Product Name: Balsalazide disodium dihydrate | CAS No.: 150399-21-6 |
Purity: 99.5% | Supply Ability: 10g |
Release date: 2025/07/16 |
Product Introduction
Bioactivity
Name | Balsalazide disodium dihydrate |
Description | Balsalazide sodium hydrate (Balsalazide disodium) is an anti-inflammatory compound used in the treatment of Inflammatory Bowel Disease.Balsalazide sodium hydrate is a new 5-aminosalicylic acid (5-ASA) containing prodrug. High dose Balsalazide sodium hydrate(3.0 g twice daily) was superior in maintaining remission in patients with ulcerative colitis compared with a low dose (1.5 g twice daily) or a standard dose of mesalazine (0.5 g three times daily). All three treatments were safe and well tolerated [1]. Balsalazide sodium hydrate is approved for the treatment of mild-to-moderate active UC. It is efficacious for the induction of remission in mild to moderate UC and has a favorable safety profile, with the added advantages of greater efficacy of remission induction and rapidity of onset [2]. |
Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice./Shipping at ambient temperature. |
Solubility Information | DMSO : 50 mg/mL (114.34 mM), Sonication is recommended. H2O : 198.9 mM, Sonication is recommended. |
Keywords | STAT | Interleukin | Balsalazide sodium | Balsalazide |
Inhibitors Related | Sodium Thiocyanate | Disulfiram | Deucravacitinib | HODHBt | Nifuroxazide | Fludarabine | Niclosamide | Diosgenin | Niclosamide olamine | Artesunate | Alantolactone | Apilimod |
Related Compound Libraries | Bioactive Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Anti-Prostate Cancer Compound Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/1kg |
Sinoway Industrial co., ltd.
|
2025-01-02 | ||
$150.00/1kg |
VIP1Y
|
Hebei Zhuanglai Chemical Trading Co Ltd
|
2024-12-17 | |
$0.00/25KG |
VIP6Y
|
Hebei Mujin Biotechnology Co.,Ltd
|
2023-09-13 | |
$1.00/1KG |
VIP8Y
|
Career Henan Chemical Co
|
2019-08-30 | |
$0.00/25KG |
VIP6Y
|
Hebei Mujin Biotechnology Co.,Ltd
|
2023-09-13 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY